AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a ...

Obesity-related cancer deaths most commonly occurred at medical facilities (n=16,243), followed by people’s homes (n=10,251), nursing and long-term care facilities (n=4446), and hospice (n=1492).

The FDA has cleared the Hilo Band (G0 Blood Pressure Monitoring System) for at-home blood pressure monitoring in adults.

Maternal hypertension is linked to poorer cognitive, language outcomes in preterm 2-year-olds, partly due to early brain abnormalities.

Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Thyroid cancer burden attributable to high BMI was increasing between 1990 and 2021 in the US, especially among men and older ...

Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with ...

Adolescents with PCOS demonstrated comparable weight loss to their reproductively normal peers after undergoing bariatric ...

Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired ...